Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Disease Area Drug discovery, Infectious diseases

Go Forth and Find a Flu Vaccine

The year 2018 marks the centenary of a flu pandemic that killed around 50 million people worldwide. Since then, significant efforts have been made to fight the flu, but a universal flu vaccine still eludes us – and thousands continue to die every year. In late April, the Bill and Melinda Gates Foundation launched a $12 million Grand Challenge: “[to] identify novel, transformative concepts that will lead to development of universal influenza vaccines offering protection from morbidity and mortality caused by all subtypes of circulating and emerging (drifted and shifted) Influenza A subtype viruses and Influenza B lineage viruses for at least three to five years”.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login as a Guest or via Social Media

Related Solutions

Disease Area

See how droplets are guiding precision medicine

| Contributed by Bio Rad

Disease Area

Improving Absorption Measurements through Light Source Selection

| Contributed by Ocean Optics

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Related Articles

Disease Area

Andes Antibody Advancement

| Jonathan James

Disease Area

More than METs the Eye

| Jonathan James

Disease Area

Just One Shot

| Stephanie Sutton

Most Popular

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register